Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli

被引:30
|
作者
Oethinger, M
Kern, WV
Goldman, JD
Levy, SB [1 ]
机构
[1] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Mol Biol, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Dept Microbiol, Boston, MA 02111 USA
[4] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[5] Tufts Univ New England Med Ctr, Boston, MA 02111 USA
[6] Univ Hosp, Sect Infect Dis & Clin Immunol, Ulm, Germany
关键词
D O I
10.1093/jac/41.1.111
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Fluoroquinolone resistance in Escherichia coli is principally caused by two kinds of mutation: those affecting the target proteins of the drugs, i.e. DNA gyrase and topoisomerase IV, and those affecting regulatory genes such as marA, soxS or robA. Recently, overexpression of the latter genes was linked to increased organic solvent tolerance in E. coli, Among 138 clinical fluoroquinolone-resistant and -susceptible clinical isolates of E. coli we found a high association between fluoroquinolone resistance and organic solvent tolerance. This finding suggests that E. coli may undergo an adaptive response to extrinsic substances other than quinolones while mutating to fluoroquinolone resistance.
引用
收藏
页码:111 / 114
页数:4
相关论文
共 50 条
  • [1] Organic solvent tolerance and fluoroquinolone resistance in Klebsiella pneumoniae clinical isolates
    Aathithan, S.
    French, G. L.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (04) : 870 - 871
  • [2] Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates
    Morgan-Linnell, Sonia K.
    Boyd, Lauren Becnel
    Steffen, David
    Zechiedrich, Lynn
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) : 235 - 241
  • [3] Emergence of fluoroquinolone resistance in Escherichia coli isolates at the Department of Clinical Hematology
    Zemkova, Marcela
    Kotlarova, Jana
    Merka, Vladimir
    Cermak, Pavel
    Vlcek, Jiri
    Jebavy, Ladislav
    [J]. NEW MICROBIOLOGICA, 2007, 30 (04): : 423 - 430
  • [4] Fluoroquinolone resistance in clinical and environmental isolates of Escherichia coli in Mexico City
    Amabile-Cuevas, C. F.
    Arredondo-Garcia, J. L.
    Cruz, A.
    Rosas, Irma
    [J]. JOURNAL OF APPLIED MICROBIOLOGY, 2010, 108 (01) : 158 - 162
  • [5] Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance
    Lehn, N
    StowerHoffmann, J
    Kott, T
    Strassner, C
    Wagner, H
    Kronke, M
    SchneiderBrachert, W
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) : 597 - 602
  • [6] Burden of Fluoroquinolone Resistance in Clinical Isolates of Escherichia coli at the Ho Teaching Hospital, Ghana
    Deku, John Gameli
    Duedu, Kwabena Obeng
    Ativi, Emmanuel
    Kpene, Godsway Edem
    Feglo, Patrick Kwame
    [J]. ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2022, 32 (01) : 93 - 102
  • [7] Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey
    Azeez, Dhay Ali
    Findik, Duygu
    Dagi, Hatice Turk
    Arslan, Ugur
    [J]. CUKUROVA MEDICAL JOURNAL, 2018, 43 (02): : 295 - 300
  • [8] Genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli
    Yamane, Takashi
    Enokida, Hideki
    Hayami, Hiroshi
    Kawahara, Motoshi
    Nakagawa, Masayuki
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (04) : 360 - 368
  • [9] Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates
    Johnson, Luke
    Sabel, Allison
    Burman, William J.
    Everhart, Rachel M.
    Rome, Marcie
    MacKenzie, Thomas D.
    Rozwadowski, Jeanne
    Mehler, Philip S.
    Price, Connie Savor
    [J]. AMERICAN JOURNAL OF MEDICINE, 2008, 121 (10): : 876 - 884
  • [10] Biofilm and fluoroquinolone resistance of canine Escherichia coli uropathogenic isolates
    Oliveira M.
    Dias F.R.
    Pomba C.
    [J]. BMC Research Notes, 7 (1)